Biomarin Pharmaceutical (BMRN) Other financing activities (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded quarterly Other financing activities of $8.7 million in Q1 2026, up 1073.34% on a QoQ basis from -$889000.0 in Q4 2025.
Biomarin Pharmaceutical (BMRN) Other financing activities (2009 - 2026) Analysis & Trends
Biomarin Pharmaceutical has disclosed Other financing activities across 17 years of filings, most recently posting $8.7 million for Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (up 347.66% YoY) and the FY2025 annual result came in at -$889000.0, up 72.02% from the prior year.
- Other financing activities grew to $8.7 million in Q1 2026, from -$889000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $8.7 million in Q1 2026 and troughed at -$9.5 million in Q4 2023.
- A 5-year average of -$942250.0 and a median of -$491500.0 in 2024 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities plunged 86933.33% — and 2024, when it soared 99.01%.
- Tracing BMRN's Other financing activities over 5 years: stood at -$2.6 million in 2022, then tumbled by 265.45% to -$9.5 million in 2023, then surged by 99.01% to -$94000.0 in 2024, then tumbled by 845.74% to -$889000.0 in 2025, then jumped by 1073.34% to $8.7 million in 2026.
- Business Quant data shows BMRN's Other financing activities at $8.7 million in Q1 2026, -$889000.0 in Q4 2025, and -$94000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Biomarin Pharmaceutical | 10.52 Bn | 8.29 Bn | 571.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.65 Mn |
| Mar 31, 2026 | 8.65 Mn |
| Dec 31, 2025 | -889,000.00 |
| Dec 31, 2025 | -889,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Sep 30, 2024 | -3.02 Mn |
| Sep 30, 2024 | -3.02 Mn |
| Jun 30, 2024 | -18,000.00 |
| Jun 30, 2024 | -18,000.00 |
| Mar 31, 2024 | -42,000.00 |
| Mar 31, 2024 | -42,000.00 |
| Dec 31, 2023 | -9.52 Mn |
| Dec 31, 2023 | -9.52 Mn |
| Dec 31, 2022 | -2.61 Mn |
| Dec 31, 2022 | -2.61 Mn |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | -20,000.00 |
| Sep 30, 2021 | -20,000.00 |